The overall objective of the Cell Function Analysis Core at the University of Washington Diabetes Research Center is to provide affiliates with analyses of glucose metabolism, mitochondrial function and intracellular signaling to support research of diabetes, obesity and related disorders. To achieve this goal, the Core aims to: (1) Provide real time functional analysis using in vitro flow culture systems of tissues/cells; (2) Provide in vivo assessments of metabolic phenotypes in rodent models important in diabetes research; (3) Provide static assessment of cellular metabolism and function; (4) Harvest, isolate and culture primary tissue from rodents, including islets and islet cells, liver, retina and brain, for subsequent morphological and functional characterization, as well as to procure human islets for the same purposes; (5) Offer training and consultation to affiliates, their trainees and staff; and (6) Develop new analytical tools requested by affiliates to support their studies of the metabolic regulation of cell function as it relates to research in diabetes, obesity and related disorders. Since inception of the Core in 2002, in vitro analysis has been the major focus. Cell and tissue types that have been analyzed include islets, retina, skeletal muscle, stem cells, macrophages, lymphocytes, adipocytes, endothelial cells, neuronal cells and liver/hepatocytes. Recently, in vivo services have been added to combine both the detailed and mechanistic analyses provided in cell and tissue studies with the ability to test the roles of identified processes in whole body settings. Whole animal studies currently offered include glucose and insulin tolerance tests, hyperinsulinemic-euglycemic clamps, islet transplantation and collection of lymph. Expansion of new in vitro, ex vivo, and in vivo services has allowed the Core to better serve the needs of the Center's research base. As diabetes affects metabolism and signaling in many cell types, the services of the Cell Function Analysis Core continue to be of great value to many Center affiliate investigators. The Core plans to continue to provide users with systematic and integrated approaches to the analysis of cell types that are critically involved in diabetes and its complications, obesity and related disorders.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
5P30DK017047-45
Application #
10077863
Study Section
Special Emphasis Panel (ZDK1)
Project Start
2018-02-10
Project End
2022-11-30
Budget Start
2020-12-01
Budget End
2021-11-30
Support Year
45
Fiscal Year
2021
Total Cost
Indirect Cost
Name
University of Washington
Department
Type
DUNS #
605799469
City
Seattle
State
WA
Country
United States
Zip Code
98195
Tanaka, Shigeru; Pfleger, Christian; Lai, Jen-Feng et al. (2018) KAP1 Regulates Regulatory T Cell Function and Proliferation in Both Foxp3-Dependent and -Independent Manners. Cell Rep 23:796-807
Houston, Denise K; Neiberg, Rebecca H; Miller, Michael E et al. (2018) Physical Function Following a Long-Term Lifestyle Intervention Among Middle Aged and Older Adults With Type 2 Diabetes: The Look AHEAD Study. J Gerontol A Biol Sci Med Sci 73:1552-1559
Guo, Rui; Hua, Yinan; Ren, Jun et al. (2018) Cardiomyocyte-specific disruption of Cathepsin K protects against doxorubicin-induced cardiotoxicity. Cell Death Dis 9:692
van Zuydam, Natalie R; Ahlqvist, Emma; Sandholm, Niina et al. (2018) A Genome-Wide Association Study of Diabetic Kidney Disease in Subjects With Type 2 Diabetes. Diabetes 67:1414-1427
Hull, Rebecca L; Gibson, Ronald L; McNamara, Sharon et al. (2018) Islet Interleukin-1? Immunoreactivity Is an Early Feature of Cystic Fibrosis That May Contribute to ?-Cell Failure. Diabetes Care 41:823-830
Koletzko, Sibylle; Lee, Hye-Seung; Beyerlein, Andreas et al. (2018) Cesarean Section on the Risk of Celiac Disease in the Offspring: The Teddy Study. J Pediatr Gastroenterol Nutr 66:417-424
Roe, Nathan D; Handzlik, Michal K; Li, Tao et al. (2018) The Role of Diacylglycerol Acyltransferase (DGAT) 1 and 2 in Cardiac Metabolism and Function. Sci Rep 8:4983
Chepurny, Oleg G; Bonaccorso, Ron L; Leech, Colin A et al. (2018) Chimeric peptide EP45 as a dual agonist at GLP-1 and NPY2R receptors. Sci Rep 8:3749
Wang, Yang; Sosinowski, Tomasz; Novikov, Andrey et al. (2018) C-terminal modification of the insulin B:11-23 peptide creates superagonists in mouse and human type 1 diabetes. Proc Natl Acad Sci U S A 115:162-167
Kikuchi, Shinsuke; Chen, Lihua; Xiong, Kevin et al. (2018) Smooth muscle cells of human veins show an increased response to injury at valve sites. J Vasc Surg 67:1556-1570.e9

Showing the most recent 10 out of 1296 publications